Scotiabank Cuts Janux Therapeutics (NASDAQ:JANX) Price Target to $41.00
Janux Therapeutics (NASDAQ:JANX – Free Report) had its price target cut by Scotiabank from $62.00 to $41.00 in a report released on Friday,Benzinga reports. They currently have a sector perform rating on the stock. JANX has been the topic of a number of other reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $200.00 […]
Janux Therapeutics (NASDAQ:JANX – Free Report) had its price target cut by Scotiabank from $62.00 to $41.00 in a report released on Friday,Benzinga reports. They currently have a sector perform rating on the stock. JANX has been the topic of a number of other reports. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $200.00 […]
